Literature DB >> 31699377

Impact of Pulmonary Hypertension Hemodynamic Status on Long-Term Outcome After Transcatheter Aortic Valve Replacement.

Jury Schewel1, Tobias Schmidt2, Karl-Heinz Kuck2, Christian Frerker2, Dimitry Schewel2.   

Abstract

OBJECTIVES: The aim of this study was to investigate the prognostic impact and development of pulmonary hypertension (PH) in the different hemodynamic subtypes of PH in patients with severe aortic stenosis (AS) undergoing transcatheter aortic valve replacement (TAVR).
BACKGROUND: PH is a frequent finding in patients with severe AS and predicts outcome after TAVR. Nevertheless, outcomes among PH subtypes and the impact of residual PH after TAVR are controversial.
METHODS: A total of 1,400 patients with symptomatic AS and full invasive hemodynamic assessment before and after TAVR were included. Patients were stratified into 4 groups: no PH (n = 658); isolated pre-capillary PH (n = 139), isolated post-capillary PH (Ipc-PH; n = 534), and combined post-capillary and pre-capillary PH (n = 69).
RESULTS: The mean overall patient age was 81.5 ± 6.8 years, and 46.3% were men. Acute device success was achieved in 94.9%. Patients without PH showed significantly lower mortality rates compared with patients with PH (1 year, 13.8% vs. 22.4% [p < 0.001]; 4 years, 37.2% vs. 51.5% [p < 0.001]). Patients with pre-capillary PH showed 1.9-fold increased 1-year mortality and those with Ipc-PH showed 1.5-fold increased 1-year mortality compared with patients without pH (p = 0.001). No differences regarding survival were found among the subgroups. Only in patients with Ipc-PH, residual PH was associated with 2.1-fold increased mortality (p = 0.010). All patients benefited in terms of functional capacity after TAVR.
CONCLUSIONS: Patients with pre-capillary PH and those with Ipc-PH showed significantly higher risk for death after TAVR compared with those without PH. Reversible PH had no benefit for survival except in patients with Ipc-PH. Hemodynamic stratification of PH is helpful for risk and response prediction in patients with AS undergoing TAVR.
Copyright © 2019 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  TAVR; aortic valve stenosis; hemodynamics; outcome; pulmonary hypertension

Year:  2019        PMID: 31699377     DOI: 10.1016/j.jcin.2019.08.031

Source DB:  PubMed          Journal:  JACC Cardiovasc Interv        ISSN: 1936-8798            Impact factor:   11.195


  6 in total

1.  Artificial intelligence-enabled phenotyping of patients with severe aortic stenosis: on the recovery of extra-aortic valve cardiac damage after transcatheter aortic valve replacement.

Authors:  Mark Lachmann; Elena Rippen; Tibor Schuster; Erion Xhepa; Moritz von Scheidt; Teresa Trenkwalder; Costanza Pellegrini; Tobias Rheude; Amelie Hesse; Anja Stundl; Gerhard Harmsen; Shinsuke Yuasa; Heribert Schunkert; Adnan Kastrati; Karl-Ludwig Laugwitz; Michael Joner; Christian Kupatt
Journal:  Open Heart       Date:  2022-10

2.  Comparison of PCWP and LVEDP Measurements in Patients with Severe Aortic Stenosis Undergoing TAVI-Same Same but Different?

Authors:  Elke Boxhammer; Moritz Mirna; Laura Bäz; Brunilda Alushi; Marcus Franz; Daniel Kretzschmar; Uta C Hoppe; Alexander Lauten; Michael Lichtenauer
Journal:  J Clin Med       Date:  2022-05-25       Impact factor: 4.964

3.  Prognostic Implications of the Novel Pulmonary Hypertension Definition in Patients with Aortic Stenosis after Transcatheter Valve Replacement.

Authors:  Dionysios Adamopoulos; Stamatia Pagoulatou; Georgios Rovas; Vasiliki Bikia; Hajo Müller; Georgios Giannakopoulos; Sarah Mauler-Wittwer; Marc-Joseph Licker; Nikolaos Stergiopulos; Frédéric Lador; Stéphane Noble
Journal:  J Clin Med       Date:  2022-07-22       Impact factor: 4.964

4.  Conundrum of Classifying Subtypes of Pulmonary Hypertension-Introducing a Novel Approach to Classify "Borderline" Patients in a Population with Severe Aortic Stenosis Undergoing TAVI.

Authors:  Elke Boxhammer; Sarah X Gharibeh; Bernhard Wernly; Malte Kelm; Marcus Franz; Daniel Kretzschmar; Uta C Hoppe; Alexander Lauten; Michael Lichtenauer
Journal:  J Cardiovasc Dev Dis       Date:  2022-09-04

5.  Impact of a volume challenge on haemodynamics and prognosis in patients with severe aortic stenosis.

Authors:  Micha T Maeder; Lukas Weber; Daniel Weilenmann; Philipp K Haager; Lucas Joerg; Franziska Rohner; Peter Ammann; Joannis Chronis; Johannes Rigger; Hans Rickli
Journal:  ESC Heart Fail       Date:  2020-11-12

6.  Soluble ST2 as a Potential Biomarker for Risk Assessment of Pulmonary Hypertension in Patients Undergoing TAVR?

Authors:  Elke Boxhammer; Moritz Mirna; Laura Bäz; Nina Bacher; Albert Topf; Brigitte Sipos; Marcus Franz; Daniel Kretzschmar; Uta C Hoppe; Alexander Lauten; Michael Lichtenauer
Journal:  Life (Basel)       Date:  2022-03-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.